| Report Title | Price | Action |
|---|---|---|
| Peroxisome Proliferator Activated Receptor Gamma (Nuclear Receptor Subfamily 1 Group C Member 3 or NR1C3 or PPARG) - Drugs in Development, 2021
Peroxisome Proliferator Activated Receptor Gamma (Nuclear Receptor Subfamily 1 Group C Member 3 or NR1C3 or PPARG) - Drugs in Development, 2021 Summa...
Published: Apr-2021 | No. of Pages: 80
|
$ 3000 | |
| D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) - Drugs in Development, 2021
D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) - Drugs in Development, 2021 Summary D1A Dopamine Receptor (Dopamine D1 Receptor or DRD1) - Dru...
Published: Apr-2021 | No. of Pages: 70
|
$ 3000 | |
| Plasmodium falciparum 25 kDa Ookinete Surface Antigen (Pfs25) - Drugs in Development, 2021
Plasmodium falciparum 25 kDa Ookinete Surface Antigen (Pfs25) - Drugs in Development, 2021 Summary Plasmodium falciparum 25 kDa Ookinete Surface Ant...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) - Drugs in Development, 2021
Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA3) - Drugs in Development, 2021 Summary Neuronal Acetylcholine Receptor Subunit Alpha 3 (CHRNA...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| B-Cell Leukemia (Oncology) - Drugs in Development, 2021
B-Cell Leukemia (Oncology) - Drugs in Development, 2021 Summary B-Cell Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the ...
Published: Apr-2021 | No. of Pages: 100
|
$ 2000 | |
| Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021
Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) (Immunology) - Drugs in Development, 2021 Summary Mucocutaneous Lymph Node Syndrome (Kawasaki D...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cells Expressing Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Drugs in Development, 2021
Cells Expressing Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or ...
Published: Apr-2021 | No. of Pages: 85
|
$ 3000 | |
| Interleukin 2 Receptor (IL2R) - Drugs in Development, 2021
Interleukin 2 Receptor (IL2R) - Drugs in Development, 2021 Summary Interleukin 2 Receptor (IL2R) - Drugs in Development, 2021 provides in depth anal...
Published: Apr-2021 | No. of Pages: 70
|
$ 3000 | |
| Plasmodium falciparum Merozoite Surface Protein 1 (Merozoite Surface Antigens or PMMSA or p190 or MSP1) - Drugs in Development, 2021
Plasmodium falciparum Merozoite Surface Protein 1 (Merozoite Surface Antigens or PMMSA or p190 or MSP1) - Drugs in Development, 2021 Summary Plasmod...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Natural Killer Cell Lymphomas (Oncology) - Drugs in Development, 2021
Natural Killer Cell Lymphomas (Oncology) - Drugs in Development, 2021 Summary Natural Killer Cell Lymphomas (Oncology) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 100
|
$ 2000 | |
| Wiskott-Aldrich Syndrome (Immunology) - Drugs in Development, 2021
Wiskott-Aldrich Syndrome (Immunology) - Drugs in Development, 2021 Summary Wiskott-Aldrich Syndrome (Immunology) - Drugs in Development, 2021 provid...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| Cholinergic Receptor Muscarinic (Muscarinic Acetylcholine Receptor or CHRM) - Drugs in Development, 2021
Cholinergic Receptor Muscarinic (Muscarinic Acetylcholine Receptor or CHRM) - Drugs in Development, 2021 Summary Cholinergic Receptor Muscarinic (Mu...
Published: Apr-2021 | No. of Pages: 85
|
$ 3000 | |
| Dipeptidyl Peptidase 4 (ADABP or Adenosine Deaminase Complexing Protein 2 or T Cell Activation Antigen CD26 or TP103 or CD26 or DPP4 or EC 3.4.14.5) - Drugs in Development, 2021
Dipeptidyl Peptidase 4 (ADABP or Adenosine Deaminase Complexing Protein 2 or T Cell Activation Antigen CD26 or TP103 or CD26 or DPP4 or EC 3.4.14.5) -...
Published: Apr-2021 | No. of Pages: 75
|
$ 3000 | |
| Poly [ADP Ribose] Polymerase 3 (ADP Ribosyltransferase Diphtheria Toxin Like 3 or NAD(+) ADP Ribosyltransferase 3 or Poly[ADP Ribose] Synthase 3 or PARP3 or EC 2.4.2.30) - Drugs in Development, 2021
Poly [ADP Ribose] Polymerase 3 (ADP Ribosyltransferase Diphtheria Toxin Like 3 or NAD(+) ADP Ribosyltransferase 3 or Poly[ADP Ribose] Synthase 3 or PA...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Development, 2021
Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Knee Osteoarthritis (Musculoskeletal Disorders) - Drugs in Deve...
Published: Apr-2021 | No. of Pages: 100
|
$ 2000 | |
| Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021
Arenaviridae Infections (Infectious Disease) - Drugs in Development, 2021 Summary Arenaviridae Infections (Infectious Disease) - Drugs in Developmen...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
| 16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021
16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 Summary 16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 provides in depth analys...
Published: Apr-2021 | No. of Pages: 85
|
$ 3000 | |
| Gonadotropin Releasing Hormone Receptor (GNRHR) - Drugs in Development, 2021
Gonadotropin Releasing Hormone Receptor (GNRHR) - Drugs in Development, 2021 Summary Gonadotropin Releasing Hormone Receptor (GNRHR) - Drugs in Deve...
Published: Apr-2021 | No. of Pages: 75
|
$ 3000 | |
| Polycomb Protein EED (WD Protein Associating With Integrin Cytoplasmic Tails 1 or WAIT1 or EED) - Drugs in Development, 2021
Polycomb Protein EED (WD Protein Associating With Integrin Cytoplasmic Tails 1 or WAIT1 or EED) - Drugs in Development, 2021 Summary Polycomb Protei...
Published: Apr-2021 | No. of Pages: 30
|
$ 3000 | |
| Adenocarcinoma (Oncology) - Drugs in Development, 2021
Adenocarcinoma (Oncology) - Drugs in Development, 2021 Summary Adenocarcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Ad...
Published: Apr-2021 | No. of Pages: 100
|
$ 2000 |